IVFAX
Price
$4.53
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Net Assets
794.44M
TROZX
Price
$23.52
Change
-$0.17 (-0.72%)
Updated
Nov 13 closing price
Net Assets
16.84B
Interact to see
Advertisement

IVFAX vs TROZX

Header iconIVFAX vs TROZX Comparison
Open Charts IVFAX vs TROZXBanner chart's image
Federated Hermes Intl Strat Val Div A
Price$4.53
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets794.44M
T. Rowe Price International Value Eq Z
Price$23.52
Change-$0.17 (-0.72%)
VolumeN/A
Net Assets16.84B
IVFAX vs TROZX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TROZX has more cash in the bank: 16.8B vs. IVFAX (794M). IVFAX pays higher dividends than TROZX: IVFAX (3.57) vs TROZX (2.64). IVFAX was incepted earlier than TROZX: IVFAX (17 years) vs TROZX (6 years). IVFAX (1.27) is less costly to investors than TROZX (0.66). IVFAX is a more actively managed with annual turnover of: 39.00 vs. TROZX (15.90). TROZX has a lower initial minimum investment than IVFAX: TROZX (0) vs IVFAX (1500). TROZX annual gain was more profitable for investors over the last year : 39.76 vs. IVFAX (25.19). TROZX return over 5 years is better than : 104.74 vs. IVFAX (62.51).
IVFAXTROZXIVFAX / TROZX
Total Expense Ratio1.110.00-
Annual Report Gross Expense Ratio1.270.66192%
Fund Existence17 years6 years-
Gain YTD28.80240.67771%
Front Load6%N/A-
Min. Initial Investment15000-
Min. Initial Investment IRAN/AN/A-
Net Assets794M16.8B5%
Annual Yield % from dividends3.572.64135%
Returns for 1 year25.1939.7663%
Returns for 3 years47.5589.5853%
Returns for 5 years62.51104.7460%
Returns for 10 years70.77N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JPIN68.740.38
+0.56%
JPMorgan Diversified Return Intl Eq ETF
KMLI17.310.05
+0.30%
KraneShares 2x Long MELI Daily ETF
SWZ6.050.01
+0.08%
Total Return Securities Inc
FDTS55.28N/A
N/A
First Trust DevMkts exUS SC AlphaDEX®ETF
GOF13.20-0.09
-0.68%
Guggenheim Strategic Opportunities Fund